Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/552
Title: | Sebaceous adenoma arising within an ovarian mature cystic teratoma in Muir-Torre syndrome | Authors: | Robertson, T. McGaughran, J. Smith, J. Crowe, K. |
Issue Date: | 2012 | Source: | December 16, (6), 2012, p. 485-488 | Pages: | 485-488 | Journal: | Annals of Diagnostic Pathology | Abstract: | This is the first reported case of a sebaceous adenoma arising within an ovarian mature cystic teratoma in a patient with Muir-Torre syndrome. The pathologic findings and a literature review are presented, including the importance and possible benefits of an early diagnosis of Muir-Torre syndrome. It is proposed that the presence of a sebaceous adenoma in an ovarian cystic teratoma may serve as a useful trigger to consider further history and investigations, with the goal of identifying an important genetic cancer predisposition syndrome. | DOI: | http://dx.doi.org/10.1016/j.anndiagpath.2011.04.003 | Resources: | http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed10&AN=2012654162 | Keywords: | Lynch syndromeMuir-Torre syndrome;Ovarian mature cystic teratoma;Sebaceous adenoma;adult;article;basal cell carcinoma;breast carcinoma;cancer risk;carcinoma;case report;cystectomy;family history;female;gene mutation;genetic counseling;genetic screening;heterozygosity;histopathology;human;human tissue;hysterectomy;immunohistochemistry;intraductal carcinoma/dt [Drug Therapy];intraductal carcinoma/rt [Radiotherapy];intraductal carcinoma/su [Surgery];intraepidermal carcinoma;keratoacanthoma;Muir Torre syndrome;nasolabial fold;ovarian mature cystic teratoma/di [Diagnosis];ovarian mature cystic teratoma/su [Surgery];pelvis radiography;preoperative evaluation;priority journal;salpingooophorectomy;sebaceous gland adenoma/di [Diagnosis];skin biopsy;skin tumor/di [Diagnosis];teratoma/di [Diagnosis];teratoma/su [Surgery];tumor volume;mismatch repair protein PMS2/ec [Endogenous Compound];protein MLH1/ec [Endogenous Compound];protein MSH2/ec [Endogenous Compound];protein MSH6/ec [Endogenous Compound];tamoxifen/dt [Drug Therapy];tamoxifen/po [Oral Drug Administration] | Type: | Article |
Appears in Sites: | Sunshine Coast HHS Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.